-
1
-
-
84856699090
-
Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
-
Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: 7S-47S.
-
Chest 2012
, vol.141
-
-
Guyatt, G.H.1
Akl, E.A.2
Crowther, M.3
-
2
-
-
34249821653
-
Prevention and treatment of major blood loss
-
Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007; 356: 2301-2311.
-
(2007)
N Engl J Med
, vol.356
, pp. 2301-2311
-
-
Mannucci, P.M.1
Levi, M.2
-
3
-
-
45949098057
-
Haemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
-
(8th Edition)
-
Schulman S, Beyth RJ, Kearon C, et al. Haemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 257S-98S.
-
Chest 2008
, vol.133
-
-
Schulman, S.1
Beyth, R.J.2
Kearon, C.3
-
4
-
-
79960638184
-
How to prevent, treat, and overcome current clinical challenges of VTE
-
Van Es J, Eerenberg ES, Kamphuisen PW, et al. How to prevent, treat, and overcome current clinical challenges of VTE. J Thromb Haemost 2011; 9 (Suppl 1): 265-274.
-
(2011)
J Thromb Haemost
, vol.9
, Issue.SUPPL. 1
, pp. 265-274
-
-
van Es, J.1
Eerenberg, E.S.2
Kamphuisen, P.W.3
-
5
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
-
6
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891.
-
(2011)
N Engl J Med
, vol.365
, pp. 883-891
-
-
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
-
7
-
-
78650619315
-
Oral rivaroxaban for symptomatic venous thromboembolism
-
Bauersachs R, Berkowitz SD, Brenner B, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010; 363: 2499-2510.
-
(2010)
N Engl J Med
, vol.363
, pp. 2499-2510
-
-
Bauersachs, R.1
Berkowitz, S.D.2
Brenner, B.3
-
8
-
-
84859385808
-
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
-
Buller HR, Prins MH, Lensin AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012; 366: 1287-1297.
-
(2012)
N Engl J Med
, vol.366
, pp. 1287-1297
-
-
Buller, H.R.1
Prins, M.H.2
Lensin, A.W.3
-
9
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992.
-
(2011)
N Engl J Med
, vol.365
, pp. 981-992
-
-
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
-
10
-
-
84863981277
-
Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation
-
Epub ahead of print
-
Miller CS, Grandi SM, Shimony A, et al. Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation. Am J Cardiol 2012; Epub ahead of print.
-
(2012)
Am J Cardiol
-
-
Miller, C.S.1
Grandi, S.M.2
Shimony, A.3
-
11
-
-
78650965540
-
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
-
Hillarp A, Baghaei F, Fagerberg B, et al. Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays. J Thromb Haemost 2011; 9: 133-139.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 133-139
-
-
Hillarp, A.1
Baghaei, F.2
Fagerberg, B.3
-
12
-
-
77953168824
-
Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
-
van Ryn J, Stangier J, Haertter S, et al. Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010; 103: 1116-1127.
-
(2010)
Thromb Haemost
, vol.103
, pp. 1116-1127
-
-
van Ryn, J.1
Stangier, J.2
Haertter, S.3
-
13
-
-
80053571188
-
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects
-
Eerenberg ES, Kamphuisen PW, Sijpkens MK, et al. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 2011; 124: 1573-1579.
-
(2011)
Circulation
, vol.124
, pp. 1573-1579
-
-
Eerenberg, E.S.1
Kamphuisen, P.W.2
Sijpkens, M.K.3
-
15
-
-
0029011723
-
Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A
-
Bi L, Lawler AM, Antonarakis SE, et al. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 1995; 10: 119-121.
-
(1995)
Nat Genet
, vol.10
, pp. 119-121
-
-
Bi, L.1
Lawler, A.M.2
Antonarakis, S.E.3
-
16
-
-
0036565867
-
Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model
-
Singh I, Smith A, Vanzieleghem B, et al. Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model. Blood 2002; 99: 3235-3240.
-
(2002)
Blood
, vol.99
, pp. 3235-3240
-
-
Singh, I.1
Smith, A.2
Vanzieleghem, B.3
-
17
-
-
59849087682
-
A human monoclonal antibody inhibiting partially factor VIII activity reduces thrombus growth in baboons
-
Jacquemin M, Stassen JM, Saint-Remy JM, et al. A human monoclonal antibody inhibiting partially factor VIII activity reduces thrombus growth in baboons. J Thromb Haemost 2009; 7: 429-437.
-
(2009)
J Thromb Haemost
, vol.7
, pp. 429-437
-
-
Jacquemin, M.1
Stassen, J.M.2
Saint-Remy, J.M.3
-
18
-
-
79953330537
-
Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: A dose-escalating, randomized, controlled trial
-
Verhamme P, Tangelder M, Verhaeghe R, et al. Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial. J Thromb Haemost 2011; 9: 664-671.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 664-671
-
-
Verhamme, P.1
Tangelder, M.2
Verhaeghe, R.3
-
19
-
-
77954655748
-
Tolerability and pharmacokinetics of TB-402 in healthy male volunteers
-
Verhamme P, Pakola S, Jensen TJ, et al. Tolerability and pharmacokinetics of TB-402 in healthy male volunteers. Clin Ther 2010; 32: 1205-1220.
-
(2010)
Clin Ther
, vol.32
, pp. 1205-1220
-
-
Verhamme, P.1
Pakola, S.2
Jensen, T.J.3
-
20
-
-
84863458846
-
Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIII
-
Tangelder M, Long C, Emmerechts J, et al. Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIII. J Thromb Haemost 2012; 10: 1371-1378.
-
(2012)
J Thromb Haemost
, vol.10
, pp. 1371-1378
-
-
Tangelder, M.1
Long, C.2
Emmerechts, J.3
-
21
-
-
5444228851
-
Disruption of protein-membrane binding and identification of small-molecule inhibitors of coagulation factor VIII
-
Spiegel PC, Kaiser SM, Simon JA, et al. Disruption of protein-membrane binding and identification of small-molecule inhibitors of coagulation factor VIII. Chem Biol 2004; 11: 1413-1422.
-
(2004)
Chem Biol
, vol.11
, pp. 1413-1422
-
-
Spiegel, P.C.1
Kaiser, S.M.2
Simon, J.A.3
-
22
-
-
0030758328
-
A factor IX-deficient mouse model for haemophilia B gene therapy
-
Wang L, Zoppe M, Hackeng TM, et al. A factor IX-deficient mouse model for haemophilia B gene therapy. Proc Natl Acad Sci USA 1997; 94: 11563-11566.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 11563-11566
-
-
Wang, L.1
Zoppe, M.2
Hackeng, T.M.3
-
23
-
-
80054964644
-
A new exogen anticoagulant with high selectivity to intrinsic pathway of coagulation
-
de Araujo RM, Vaz AF, Santos ME, et al. A new exogen anticoagulant with high selectivity to intrinsic pathway of coagulation. Thromb Res 2011; 128: 395-397.
-
(2011)
Thromb Res
, vol.128
, pp. 395-397
-
-
de Araujo, R.M.1
Vaz, A.F.2
Santos, M.E.3
-
24
-
-
9744281932
-
Molecular diversity and accelerated evolution of C-type lectin-like proteins from snake venom
-
Ogawa T, Chijiwa T, Oda-Ueda N, et al. Molecular diversity and accelerated evolution of C-type lectin-like proteins from snake venom. Toxicon 2005; 45: 1-14.
-
(2005)
Toxicon
, vol.45
, pp. 1-14
-
-
Ogawa, T.1
Chijiwa, T.2
Oda-Ueda, N.3
-
25
-
-
79960282221
-
Factor IXa as a target for pharmacologic inhibition in acute coronary syndrome
-
Roser-Jones C, Chan M, Howard EL, et al. Factor IXa as a target for pharmacologic inhibition in acute coronary syndrome. Cardiovasc Ther 2011; 29: e22-e35.
-
(2011)
Cardiovasc Ther
, vol.29
-
-
Roser-Jones, C.1
Chan, M.2
Howard, E.L.3
-
26
-
-
78649726923
-
Nitrophorin 2, a factor IX (a)-directed anticoagulant, inhibits arterial thrombosis without impairing haemostasis
-
Mizurini DM, Francischetti IM, Andersen JF, et al. Nitrophorin 2, a factor IX (a)-directed anticoagulant, inhibits arterial thrombosis without impairing haemostasis. Thromb Haemost 2010; 104: 1116-1123.
-
(2010)
Thromb Haemost
, vol.104
, pp. 1116-1123
-
-
Mizurini, D.M.1
Francischetti, I.M.2
Andersen, J.F.3
-
27
-
-
39549104685
-
Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: An exploratory study
-
Eriksson BI, Dahl OE, Lassen MR, et al. Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study. J Thromb Haemost 2008; 6: 457-463.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 457-463
-
-
Eriksson, B.I.1
Dahl, O.E.2
Lassen, M.R.3
-
28
-
-
80054052562
-
Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy
-
Povsic TJ, Wargin WA, Alexander JH, et al. Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy. Eur Heart J 2011; 32: 2412-2419.
-
(2011)
Eur Heart J
, vol.32
, pp. 2412-2419
-
-
Povsic, T.J.1
Wargin, W.A.2
Alexander, J.H.3
-
29
-
-
0037276211
-
Complications of central venous access devices in paediatric haemophilia patients
-
Domm JA, Hudson MG, Janco RL. Complications of central venous access devices in paediatric haemophilia patients. Haemophilia 2003; 9: 50-56.
-
(2003)
Haemophilia
, vol.9
, pp. 50-56
-
-
Domm, J.A.1
Hudson, M.G.2
Janco, R.L.3
-
30
-
-
0033056524
-
Central venous catheter-associated thrombosis in severe haemophilia
-
Vidler V, Richards M, Vora A. Central venous catheter-associated thrombosis in severe haemophilia. Br J Haematol 1999; 104: 461-464.
-
(1999)
Br J Haematol
, vol.104
, pp. 461-464
-
-
Vidler, V.1
Richards, M.2
Vora, A.3
-
31
-
-
77953865333
-
Subclinical deep venous thrombosis observed in 10% of haemophilic patients undergoing major orthopedic surgery
-
Hermans C, Hammer F, Lobet S, et al. Subclinical deep venous thrombosis observed in 10% of haemophilic patients undergoing major orthopedic surgery. J Thromb Haemost 2010; 8: 1138-1140.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 1138-1140
-
-
Hermans, C.1
Hammer, F.2
Lobet, S.3
-
32
-
-
33646413436
-
Non-catheter associated venous thrombosis in haemophilia A and B.A critical review of all reported cases
-
Girolami A, Scandellari R, Zanon E, et al. Non-catheter associated venous thrombosis in haemophilia A and B. A critical review of all reported cases. J Thromb Thrombolysis 2006; 21: 279-284.
-
(2006)
J Thromb Thrombolysis
, vol.21
, pp. 279-284
-
-
Girolami, A.1
Scandellari, R.2
Zanon, E.3
-
33
-
-
33747432663
-
Myocardial infarction and other arterial occlusions in haemophilia a patients.A cardiological evaluation of all 42 cases reported in the literature
-
Girolami A, Ruzzon E, Fabris F, et al. Myocardial infarction and other arterial occlusions in haemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol 2006; 116: 120-125.
-
(2006)
Acta Haematol
, vol.116
, pp. 120-125
-
-
Girolami, A.1
Ruzzon, E.2
Fabris, F.3
-
34
-
-
24944508772
-
Myocardial infarction, other arterial thrombosis and invasive coronary procedures, in hemaophilia B: A critical evaluation of reported cases
-
Girolami A, Randi ML, Ruzzon E, et al. Myocardial infarction, other arterial thrombosis and invasive coronary procedures, in hemaophilia B: a critical evaluation of reported cases. J Thromb Thrombolysis 2005; 20: 43-46.
-
(2005)
J Thromb Thrombolysis
, vol.20
, pp. 43-46
-
-
Girolami, A.1
Randi, M.L.2
Ruzzon, E.3
-
35
-
-
73049107202
-
Coronary atherosclerosis and cardiovascular mortality in haemophilia
-
Foley CJ, Nichols L, Jeong K, et al. Coronary atherosclerosis and cardiovascular mortality in haemophilia. J Thromb Haemost 2010; 8: 208-211.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 208-211
-
-
Foley, C.J.1
Nichols, L.2
Jeong, K.3
-
36
-
-
84855414141
-
Coronary artery calcification score and carotid intima-media thickness in patients with haemophilia
-
Zwiers M, Lefrandt JD, Mulder DJ, et al. Coronary artery calcification score and carotid intima-media thickness in patients with haemophilia. J Thromb Haemost 2012; 10: 23-29.
-
(2012)
J Thromb Haemost
, vol.10
, pp. 23-29
-
-
Zwiers, M.1
Lefrandt, J.D.2
Mulder, D.J.3
-
37
-
-
84861526902
-
Elevated factor VIII levels and risk of venous thrombosis
-
Jenkins PV, Rawley O, Smith OP, et al. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol 2012; 157: 653-663.
-
(2012)
Br J Haematol
, vol.157
, pp. 653-663
-
-
Jenkins, P.V.1
Rawley, O.2
Smith, O.P.3
-
39
-
-
0042671199
-
Decreased mortality of ischaemic heart disease among carriers of haemophilia
-
Sramek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003; 362: 351-354.
-
(2003)
Lancet
, vol.362
, pp. 351-354
-
-
Sramek, A.1
Kriek, M.2
Rosendaal, F.R.3
-
42
-
-
78149254900
-
Coagulation factor XI as a novel target for antithrombotic treatment
-
Lowenberg EC, Meijers JC, Monia BP, et al. Coagulation factor XI as a novel target for antithrombotic treatment. J Thromb Haemost 2010; 8: 2349-2357.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 2349-2357
-
-
Lowenberg, E.C.1
Meijers, J.C.2
Monia, B.P.3
-
43
-
-
80051794851
-
Factor XI and XII as antithrombotic targets
-
Muller F, Gailani D, Renne T. Factor XI and XII as antithrombotic targets. Curr Opin Hematol 2011; 18: 349-355.
-
(2011)
Curr Opin Hematol
, vol.18
, pp. 349-355
-
-
Muller, F.1
Gailani, D.2
Renne, T.3
-
45
-
-
0036212988
-
FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse
-
Rosen ED, Gailani D, Castellino FJ. FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse. Thromb Haemost 2002; 87: 774-776.
-
(2002)
Thromb Haemost
, vol.87
, pp. 774-776
-
-
Rosen, E.D.1
Gailani, D.2
Castellino, F.J.3
-
46
-
-
59649103257
-
Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
-
Tucker EI, Marzec UM, White TC, et al. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. Blood 2009; 113: 936-944.
-
(2009)
Blood
, vol.113
, pp. 936-944
-
-
Tucker, E.I.1
Marzec, U.M.2
White, T.C.3
-
47
-
-
84863229481
-
Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys
-
Younis HS, Crosby J, Huh JI, et al. Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys. Blood 2012; 119: 2401-2408.
-
(2012)
Blood
, vol.119
, pp. 2401-2408
-
-
Younis, H.S.1
Crosby, J.2
Huh, J.I.3
-
48
-
-
78649471947
-
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: A novel antithrombotic strategy with lowered bleeding risk
-
Zhang H, Lowenberg EC, Crosby JR, et al. Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. Blood 2010; 116: 4684-4692.
-
(2010)
Blood
, vol.116
, pp. 4684-4692
-
-
Zhang, H.1
Lowenberg, E.C.2
Crosby, J.R.3
-
49
-
-
43249088304
-
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
-
Salomon O, Steinberg DM, Koren-Morag N, et al. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood 2008; 111: 4113-4117.
-
(2008)
Blood
, vol.111
, pp. 4113-4117
-
-
Salomon, O.1
Steinberg, D.M.2
Koren-Morag, N.3
-
50
-
-
0142197166
-
Inherited factor XI deficiency confers no protection against acute myocardial infarction
-
Salomon O, Steinberg DM, Dardik R, et al. Inherited factor XI deficiency confers no protection against acute myocardial infarction. J Thromb Haemost 2003; 1: 658-661.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 658-661
-
-
Salomon, O.1
Steinberg, D.M.2
Dardik, R.3
-
51
-
-
79851476826
-
Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis
-
Salomon O, Steinberg DM, Zucker M, et al. Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis. Thromb Haemost 2011; 105: 269-273.
-
(2011)
Thromb Haemost
, vol.105
, pp. 269-273
-
-
Salomon, O.1
Steinberg, D.M.2
Zucker, M.3
-
52
-
-
0025815673
-
Factor XI deficiency in Ashkenazi Jews in Israel
-
Asakai R, Chung DW, Davie EW, et al. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325: 153-158.
-
(1991)
N Engl J Med
, vol.325
, pp. 153-158
-
-
Asakai, R.1
Chung, D.W.2
Davie, E.W.3
-
54
-
-
0028869947
-
Definition of the bleeding tendency in factor XI-deficient kindreds--a clinical and laboratory study
-
Bolton-Maggs P., Patterson DA, Wensley RT, et al. Definition of the bleeding tendency in factor XI-deficient kindreds--a clinical and laboratory study. Thromb Haemost 1995; 73: 194-202.
-
(1995)
Thromb Haemost
, vol.73
, pp. 194-202
-
-
Bolton-Maggs, P.1
Patterson, D.A.2
Wensley, R.T.3
-
56
-
-
67849097372
-
Factor XI deficiency in humans
-
Seligsohn U. Factor XI deficiency in humans. J Thromb Haemost 2009; 7 (Suppl 1): 84-87.
-
(2009)
J Thromb Haemost
, vol.7
, Issue.SUPPL. 1
, pp. 84-87
-
-
Seligsohn, U.1
-
59
-
-
78651487170
-
Comparative incidence of thrombosis in reported cases of deficiencies of factors of the contact phase of blood coagulation
-
Girolami A, Candeo N, De Marinis GB, et al. Comparative incidence of thrombosis in reported cases of deficiencies of factors of the contact phase of blood coagulation. J Thromb Thrombolysis 2011; 31: 57-63.
-
(2011)
J Thromb Thrombolysis
, vol.31
, pp. 57-63
-
-
Girolami, A.1
Candeo, N.2
de Marinis, G.B.3
-
60
-
-
33645066112
-
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with haemostasis
-
Kleinschnitz C, Stoll G, Bendszus M, et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with haemostasis. J Exp Med 2006; 203: 513-518.
-
(2006)
J Exp Med
, vol.203
, pp. 513-518
-
-
Kleinschnitz, C.1
Stoll, G.2
Bendszus, M.3
-
61
-
-
78149428887
-
A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo
-
Cheng Q, Tucker EI, Pine MS, et al. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood 2010; 116: 3981-3989.
-
(2010)
Blood
, vol.116
, pp. 3981-3989
-
-
Cheng, Q.1
Tucker, E.I.2
Pine, M.S.3
-
62
-
-
81155133305
-
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding
-
Revenko AS, Gao D, Crosby JR, et al. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. Blood 2011; 118: 5302-5311.
-
(2011)
Blood
, vol.118
, pp. 5302-5311
-
-
Revenko, A.S.1
Gao, D.2
Crosby, J.R.3
-
63
-
-
22944462705
-
Defective thrombus formation in mice lacking coagulation factor XII
-
Renne T, Pozgajova M, Gruner S, et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005; 202: 271-281.
-
(2005)
J Exp Med
, vol.202
, pp. 271-281
-
-
Renne, T.1
Pozgajova, M.2
Gruner, S.3
-
64
-
-
4544235711
-
Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo
-
Pauer HU, Renne T, Hemmerlein B, et al. Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo. Thromb Haemost 2004; 92: 503-508.
-
(2004)
Thromb Haemost
, vol.92
, pp. 503-508
-
-
Pauer, H.U.1
Renne, T.2
Hemmerlein, B.3
-
65
-
-
84861727362
-
Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: Murine Ortholog of the Fletcher Trait
-
Bird JE, Smith PL, Wang X, et al. Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: Murine Ortholog of the Fletcher Trait. Thromb Haemost 2012; 107: 1141-1150.
-
(2012)
Thromb Haemost
, vol.107
, pp. 1141-1150
-
-
Bird, J.E.1
Smith, P.L.2
Wang, X.3
-
66
-
-
79953816704
-
Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis
-
Adams GN, LaRusch GA, Stavrou E, et al. Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis. Blood 2011; 117: 3929-3937.
-
(2011)
Blood
, vol.117
, pp. 3929-3937
-
-
Adams, G.N.1
Larusch, G.A.2
Stavrou, E.3
-
67
-
-
38949099750
-
Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis
-
Merkulov S, Zhang WM, Komar AA, et al. Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis. Blood 2008; 111: 1274-1281.
-
(2008)
Blood
, vol.111
, pp. 1274-1281
-
-
Merkulov, S.1
Zhang, W.M.2
Komar, A.A.3
-
68
-
-
84868603189
-
Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain-barrier damage and inflammation
-
Epub ahead of print
-
Langhauser F, Gob E, Kraft P, et al. Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain-barrier damage and inflammation. Blood 2012; Epub ahead of print.
-
(2012)
Blood
-
-
Langhauser, F.1
Gob, E.2
Kraft, P.3
-
69
-
-
34250170510
-
The intrinsic pathway of coagulation: A target for treating thromboembolic disease?
-
Gailani D, Renne T. The intrinsic pathway of coagulation: a target for treating thromboembolic disease? J Thromb Haemost 2007; 5: 1106-1112.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1106-1112
-
-
Gailani, D.1
Renne, T.2
-
70
-
-
67349194274
-
The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified
-
Girolami A, Scarparo P, Vettore S. The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified. J Thromb Thrombolysis 2009; 27: 454-455.
-
(2009)
J Thromb Thrombolysis
, vol.27
, pp. 454-455
-
-
Girolami, A.1
Scarparo, P.2
Vettore, S.3
-
71
-
-
64749107219
-
Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: A risk factor for both venous and arterial thrombosis
-
Lessiani G, Falco A, Nicolucci E, et al. Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis. J Thromb Thrombolysis 2009; 27: 348-351.
-
(2009)
J Thromb Thrombolysis
, vol.27
, pp. 348-351
-
-
Lessiani, G.1
Falco, A.2
Nicolucci, E.3
-
72
-
-
67349197811
-
Relationship between factor XII deficiency and thrombosis: The debate is still open?
-
Lessiani G, Falco A, Nicolucci E, et al. Relationship between factor XII deficiency and thrombosis: the debate is still open? J Thromb Thrombolysis 2009; 27: 456-457.
-
(2009)
J Thromb Thrombolysis
, vol.27
, pp. 456-457
-
-
Lessiani, G.1
Falco, A.2
Nicolucci, E.3
-
73
-
-
70449472262
-
Coagulation factors IX through XIII and the risk of future venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology
-
Cushman M, O-Meara ES, Folsom AR, et al. Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood 2009; 114: 2878-2883.
-
(2009)
Blood
, vol.114
, pp. 2878-2883
-
-
Cushman, M.1
O-Meara, E.S.2
Folsom, A.R.3
-
74
-
-
78650633950
-
The factor XII -4C> T variant and risk of common thrombotic disorders: A HuGE review and meta-analysis of evidence from observational studies
-
Johnson CY, Tuite A, Morange PE, et al. The factor XII -4C> T variant and risk of common thrombotic disorders: A HuGE review and meta-analysis of evidence from observational studies. Am J Epidemiol 2011; 173: 136-144.
-
(2011)
Am J Epidemiol
, vol.173
, pp. 136-144
-
-
Johnson, C.Y.1
Tuite, A.2
Morange, P.E.3
-
75
-
-
33845497457
-
Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII
-
Doggen CJ, Rosendaal FR, Meijers JC. Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. Blood 2006; 108: 4045-4051.
-
(2006)
Blood
, vol.108
, pp. 4045-4051
-
-
Doggen, C.J.1
Rosendaal, F.R.2
Meijers, J.C.3
-
76
-
-
34548059728
-
The plasma kallikrein-kinin system and risk of cardiovascular disease in men
-
Govers-Riemslag JW, Smid M, Cooper JA, et al. The plasma kallikrein-kinin system and risk of cardiovascular disease in men. J Thromb Haemost 2007; 5: 1896-1903.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1896-1903
-
-
Govers-Riemslag, J.W.1
Smid, M.2
Cooper, J.A.3
-
77
-
-
78349308080
-
Intrinsic coagulation activation and the risk of arterial thrombosis in young women: Results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) casecontrol study
-
Siegerink B, Govers-Riemslag JW, Rosendaal FR, et al. Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) casecontrol study. Circulation 2010; 122: 1854-1861.
-
(2010)
Circulation
, vol.122
, pp. 1854-1861
-
-
Siegerink, B.1
Govers-Riemslag, J.W.2
Rosendaal, F.R.3
-
78
-
-
34250191847
-
Evidence of a U-shaped association between factor XII activity and overall survival
-
Endler G, Marsik C, Jilma B, et al. Evidence of a U-shaped association between factor XII activity and overall survival. J Thromb Haemost 2007; 5: 1143-1148.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1143-1148
-
-
Endler, G.1
Marsik, C.2
Jilma, B.3
-
79
-
-
84869854718
-
In vivo roles of factor XII
-
Epub ahead of print
-
Renne T, Schmaier AH, Nickel KF, et al. In vivo roles of factor XII. Blood 2012; Epub ahead of print.
-
(2012)
Blood
-
-
Renne, T.1
Schmaier, A.H.2
Nickel, K.F.3
-
80
-
-
84861750668
-
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
-
von Bruhl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209: 819-835.
-
(2012)
J Exp Med
, vol.209
, pp. 819-835
-
-
von Bruhl, M.L.1
Stark, K.2
Steinhart, A.3
-
81
-
-
0028943962
-
Venous thrombosis-associated inflammation and attenuation with neutralising antibodies to cytokines and adhesion molecules
-
Wakefield TW, Strieter RM, Wilke CA, et al. Venous thrombosis-associated inflammation and attenuation with neutralising antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15: 258-268.
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 258-268
-
-
Wakefield, T.W.1
Strieter, R.M.2
Wilke, C.A.3
-
82
-
-
0032525041
-
Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation
-
Johnson K, Choi Y, DeGroot E, et al. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 1998; 160: 5130-5135.
-
(1998)
J Immunol
, vol.160
, pp. 5130-5135
-
-
Johnson, K.1
Choi, Y.2
Degroot, E.3
-
83
-
-
1542287347
-
Neutrophil extracellular traps kill bacteria
-
Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532-1535.
-
(2004)
Science
, vol.303
, pp. 1532-1535
-
-
Brinkmann, V.1
Reichard, U.2
Goosmann, C.3
-
84
-
-
84864289224
-
Neutrophil Extracellular Trap (NET) Impact on Deep Vein Thrombosis
-
Fuchs TA, Brill A, Wagner DD. Neutrophil Extracellular Trap (NET) Impact on Deep Vein Thrombosis. Arterioscler Thromb Vasc Biol 2012; 32: 1777-1783.
-
(2012)
Arterioscler Thromb Vasc Biol
, vol.32
, pp. 1777-1783
-
-
Fuchs, T.A.1
Brill, A.2
Wagner, D.D.3
-
85
-
-
0022545432
-
Purified plasma factor XIIa aggregates human neutrophils and causes degranulation
-
Wachtfogel YT, Pixley RA, Kucich U, et al. Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. Blood 1986; 67: 1731-1737.
-
(1986)
Blood
, vol.67
, pp. 1731-1737
-
-
Wachtfogel, Y.T.1
Pixley, R.A.2
Kucich, U.3
-
86
-
-
0021052373
-
Human plasma kallikrein releases neutrophil elastase during blood coagulation
-
Wachtfogel YT, Kucich U, James HL, et al. Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest 1983; 72: 1672-1677.
-
(1983)
J Clin Invest
, vol.72
, pp. 1672-1677
-
-
Wachtfogel, Y.T.1
Kucich, U.2
James, H.L.3
-
87
-
-
0028236815
-
Assembly of contact-phase factors on the surface of the human neutrophil membrane
-
Henderson LM, Figueroa CD, Muller-Esterl W, et al. Assembly of contact-phase factors on the surface of the human neutrophil membrane. Blood 1994; 84: 474-482.
-
(1994)
Blood
, vol.84
, pp. 474-482
-
-
Henderson, L.M.1
Figueroa, C.D.2
Muller-Esterl, W.3
-
88
-
-
55249100301
-
Novel roles for factor XII-driven plasma contact activation system
-
Muller F, Renne T. Novel roles for factor XII-driven plasma contact activation system. Curr Opin Hematol 2008; 15: 516-521.
-
(2008)
Curr Opin Hematol
, vol.15
, pp. 516-521
-
-
Muller, F.1
Renne, T.2
-
89
-
-
84859707412
-
The procoagulant and proinflammatory plasma contact system
-
Renne T. The procoagulant and proinflammatory plasma contact system. Semin Immunopathol 2012; 34: 31-41.
-
(2012)
Semin Immunopathol
, vol.34
, pp. 31-41
-
-
Renne, T.1
-
90
-
-
84862729665
-
Polyphosphate: An ancient molecule that links platelets, coagulation, and inflammation
-
Morrissey JH, Choi SH, Smith SA. Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. Blood 2012; 119: 5972-5979.
-
(2012)
Blood
, vol.119
, pp. 5972-5979
-
-
Morrissey, J.H.1
Choi, S.H.2
Smith, S.A.3
-
91
-
-
84862865744
-
Polyphosphate: A link between platelets, coagulation and inflammation
-
Morrissey JH. Polyphosphate: a link between platelets, coagulation and inflammation. Int J Hematol 2012; 95: 346-352.
-
(2012)
Int J Hematol
, vol.95
, pp. 346-352
-
-
Morrissey, J.H.1
-
92
-
-
77649125820
-
Coagulation factor IXa as a target for treatment and prophylaxis of venous thromboembolism
-
Eikelboom JW, Zelenkofske SL, Rusconi CP. Coagulation factor IXa as a target for treatment and prophylaxis of venous thromboembolism. Arterioscler Thromb Vasc Biol 2010; 30: 382-387.
-
(2010)
Arterioscler Thromb Vasc Biol
, vol.30
, pp. 382-387
-
-
Eikelboom, J.W.1
Zelenkofske, S.L.2
Rusconi, C.P.3
|